07-01 IDEXX Laboratories to Release 2026 Second Quarter Financial Results BU
06-29 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell Midcap Value Benchmark CI
06-29 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Value Benchmark CI
06-28 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 3000E Value Benchmark CI
06-28 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 3000 Value Benchmark CI
06-28 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Value-Defensive Index CI
06-28 IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Dynamic Index CI
05-27 IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2026, May-27-2026 10:55 AM
05-26 IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection MT
05-26 IDEXX Laboratories Expands Fecal Dx Antigen Testing Platform With Taeniid Tapeworm Detection CI
05-26 IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection BU
05-19 IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles BU
05-19 Idexx Laboratories, Inc. Integrates Sdma into Catalyst Chemistry Profiles CI
05-14 IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day BU
05-06 Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655 MT
05-06 Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785 MT
05-05 IDEXX Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) PU
05-05 Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. CI
05-05 IDEXX Laboratories, Inc., Q1 2026 Earnings Call, May 05, 2026
05-05 IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise MT
05-05 IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-05 IDEXX raises annual forecasts on strong pet diagnostics demand RE
05-05 IDEXX Laboratories Q1 Comparable Earnings, Revenue Rise MT
05-05 Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Comparable EPS $3.30, vs. FactSet Est of $3.39 MT
05-05 Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q1 Revenue $1.14B, vs. FactSet Est of $1.12B MT
No results match your criteria
  1. Stock Market
  2. Stocks
  3. IDXX Stock
  4. News IDEXX Laboratories, Inc.